Chronic Lymphocytic Leukemia: Monoclonal Antibodies Will Drive Steady Growth

Table of Contents

• Introduction
• Leukemia
• Characteristics
• Etiology and Pathophysiology
• Symptoms
• Staging and Survival
• Epidemiology
• Prognosis
• Options for Chronic Lymphocytic Leukemia
• Treatment
• Decisions
• Line Therapies
• Second-Line Therapies
• Therapies
• Emerging Therapies for Chronic Lymphocytic
• Leukemia
• Antibodies
• Rituximab
• Lumiliximab
• Other Monoclonal Antibodies
• Immunotoxins
• Inhibitors
• Antisense Oligonucleotides
• Outlook
• Table 1 Common Staging Systems Used in the Treatment of CLL
• Table 2 Select Current Therapies Used for the Treatment of CLL, 2006
• Table 3 NCI Definition of Response to Treatment in CLL Patients
• Table 4 Select Emerging Therapies for the Treatment of CLL in the United States, 2006
• Figure 1 Treatment Algorithm for Chronic Lymphocytic Leukemia